Official UK procurement notice
Pathology Equipment for PCR Testing
Authority: MEDICINES DISCOVERY CATAPULT LIMITED (Public body)
What is being bought
Published requirement descriptionMedicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
CPV: Medical equipments, pharmaceuticals and personal care products
The lotProcurement structure
single lot · no lot value publishedLot #1Medicines Discovery Catapult Services Ltd (MDCS) has agreed a contract with SynLab…Awarded
Medicines Discovery Catapult Services Ltd (MDCS) has agreed a contract with SynLab Laboratory Services (SynLab) for the MDCS to provide SynLab with SARS-CoV-2 tests. The agreement also includes agreement for SynLab to lease to a potential purchase the below equipment to MDCS, for a value in the region of £200,000.00:
Thermo Fisher Life Technologies - KF FLX 96 DEEP, SMST, 1YZG11 Quantity 2
Thermo Fisher Life Technologies - CORD,PWR 10A/240V-C13-UK 2.5M Quantity 2
Thermo Fisher Life Technologies QSTUDIO 7 FLX, 384W INST,LPTP Quantity 1
Thermo Fisher Life Technologies 384-WELL CALIBRATION INSTALL KIT Quantity 1
Thermo Fisher Life Technologies POWER CORD-UK EACH Quantity 1
Thermo Fisher Life Technologies 1 DAY REAL TIME PCR TRAINING AT CUSTOMER SITE
Thermo Fisher Life Technologies ASSURANCE,QSTUDIO7FLEX Quantity 1
Thermo Fisher Life Technologies 384WELL CALIBRATOR W/ABY DYE Quantity 1
Thermo Fisher Life Technologies384WELL CALIBRATOR Quantity 1
Thermo Fisher Scientific BSC Herasafe 2030i 1.5m incUVC, stand, frame, delivery, commissioning, KSN Top box Quantity 2
Cepheid GeneXpert: GXIV‐4‐L‐10C Description GeneXpert IV Laptop ‐ 4 Modules ‐ 10 colours
(including 1 years service agreement) Quantity 1
Capheid Xpert Xpress SARS-CoV-2 20 kits Quantity 1 Additional information: md.catapult.org.uk ↗
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 23 Jul 2021, 19:37 BST
- Last source update
- 23 Jul 2021, 19:37 BST
- Authority reference
DN558694- FTS notice number
2021/S 000-017561- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02cc07Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
Medicines Discovery Catapult Services Ltd (MDCS) has agreed a contract with SynLab Laboratory Services (SynLab) for the MDCS to provide SynLab with SARS-CoV-2 tests. The intention is that SynLab will utilise the MDCS as a referral laboratory to assist with analysing of Sars-CoV-2 Samples. The MDCS will be analysing the Samples provided to it following the Sars-CoV-2 Tests using equipment owned and provided by the SynLab as per the Equipment Hire Agreement dated 10th June 2021 the MDCS have the option to purchase the equipment at the end of the contract.
A condition of the contract is that the MDCS must operate the Thermo Fisher Life Technologies Equipment which in turn requires the use of specific reagents for PCR COVID testing.
The MDCS must operate the Thermo Fisher Life Technologies equipment and relevant reagents to ensure that the analysis being carried out on the biological samples provided by SynLab will produce data that is compliant with our current UKAS accreditation.
- Review procedure
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| SYNLAB Laboratory Services | £200,000 † | — | Awarded |
Contracts
Pathology Equipment for PCR Testing · SYNLAB Laboratory Services
- Signed
- 10 Jun 2021
- Value
- £200,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Medicines Discovery Catapult LtdMediation bodyReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- SYNLAB Laboratory ServicesAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.